—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Globus Medical (GMED) — chart, structure and Closelooknet read

The Closelooknet read

Globus Medical makes implants and instruments for spine, orthopaedic trauma and hip-and-knee surgery, treating musculoskeletal disorders. It also builds the ExcelsiusGPS robotic guidance platform and related navigation and neuromonitoring tools used during procedures.

Detail below: the desk's view, the earnings record, peers and the company snapshot; daily prices on the price-history tab. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for GMED, from the same nightly bakes the boards use. Research diary readings, not advice.

Versus its index HALO Growth 100 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

HALO Growth 100 · as of 2026-11-06

DayWeekMonth3 months
GMED−12.8%−9.0%−3.1%−17.5%
Surgical, Med Devices & Animal Health−3.2%+4.6%+13.6%—
HALO Growth 100+0.3%+0.6%+1.3%—

Against the index: 9.6 pts behind on the week, 4.4 pts behind on the month; against its Surgical, Med Devices & Animal Health sleeve 16.7 pts behind on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 47/100 · S&P 500 fund at 48, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-11-06
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 60th percentile of the window, -22.8% over 20 sessions. Factor regime → 2026-11-06
  • Sector × region Health care in US: −0.0% week · +9.9% month · +10.1% quarter · +26.4% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-11-06
  • Sovereign pressure Index -1.91 · down 2.45 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-11-06
How it trades on rate days beta 0.86 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How GMED has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.86 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Globus Medical moved 0.86% on average · correlation 0.16 · higher than 74% of US names
  • Beta, last 3 months 1.00 about the same as over the year
  • On the 10 worst bond days −0.94% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +0.42% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against HALO Growth 100 · Surgical, Med Devices & Animal Health · 7 names with week and year-to-date

Peer group

HALO Growth 100 · Surgical, Med Devices & Animal Health

Robotic surgery, continuous-glucose sensors, cochlear implants, animal-health platforms. Regulated moats, multi-decade compounders.

Compared against GMED on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Globus Medical

GMED in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Globus Medical makes implants and instruments for spine, orthopaedic trauma and hip-and-knee surgery, treating musculoskeletal disorders. It also builds the ExcelsiusGPS robotic guidance platform and related navigation and neuromonitoring tools used during procedures. The company is based in Audubon, United States, and sells through direct and distributor channels in the US and abroad.
Where it sits in the stack
Globus Medical carries no seat in Rubin or Halo, our AI-stack indices; it sits instead in the HALO Growth 100, our growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve, a group of regulated device and diagnostics compounders.
Who it is priced against
Closelooknet's peer group places it with regulated medical-device and animal-health names — IDEXX Laboratories, Intuitive Surgical, Sonova, Stryker, Sartorius, DexCom and Insulet — grouped for their multi-decade regulatory moats; the market also compares it with Medtronic.
Why Closelooknet tracks it
Globus Medical is a HALO Growth 100 constituent and carries a Closelooknet score across seven modules, where valuation reads strongest and momentum weakest; the diary has not yet quoted it directly.
What the diary watches
Whether the stock's slide below its 50-day and 200-day levels and its weak place on the Directional Flow list steadies, or whether adoption of the Excelsius robotic platforms lifts the read.

Globus Medical (GMED) trades on US exchanges, classified under Healthcare. Constituent of HALO Growth 100.

The Closelooknet company score reads 59/100 composite (momentum 31, quality 65, valuation 53) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 2 analyst actions on the wire · latest: downgrade by BMO Capital, 2026-11-06 · last print 2026-11-05

The Street on this name

Analyst actions and the latest print for GMED from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Downgrade BMO Capital — Outperform → Market Perform Downgraded to Market Perform from Outperform 2026-11-06
  • Price target RBC Capital — target 85 from 115 Target cut to $85 from $115 (+13.5% to spot) 2026-10-01
  • Latest print EPS 1.23 against 1.20 expected — a +2.5% beat 2026-11-05

2 actions on the analyst wire since 2026-08-13: 1 downgrade, 1 target change. Analyst wire → · Earnings wire →

Dividends and capital return no distribution in twelve months · buybacks 300 m USD in FY2025

Dividends and capital return

What GMED pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Buybacks, FY2025 300 m USD 2.8% of today's market value
  • Share count −0.5% in FY2025 50 m USD of stock-based compensation in the year
  • Capital returned 300 m USD · 51% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-11-07

Quick answers

What is Globus Medical (GMED)?

Globus Medical trades as GMED on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-11-07.

Is GMED in a Closelooknet index?

Yes — Globus Medical is a constituent of HALO Growth 100, as of 2026-11-07.

What is Globus Medical's Closelooknet composite score?

59 out of 100, with momentum 31, quality 65 and valuation 53 sub-scores, as of 2026-11-07. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does GMED trade against its moving averages?

Globus Medical trades 5.2% above its 50-day and 2.2% below its 200-day moving average (2.6% above its 20-day). As of 2026-11-05 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is GMED doing against its Closelooknet index?

Over the past month Globus Medical is −3.1% against +1.3% for the HALO Growth 100 — 4.4 points behind its index, as of 2026-11-06. Its Surgical, Med Devices & Animal Health sleeve is +13.6% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

How does Globus Medical compare with its peers?

Against its peer group (HALO Growth 100 · Surgical, Med Devices & Animal Health), Globus Medical (GMED) sits 19.7% below its 52-week high, 5.2% above its 50-day average; DexCom Inc (DXCM) is 8.8% below, IDEXX Laboratories Inc (IDXX) is 12.9% below, Intuitive Surgical Inc (ISRG) is 22.4% below, as of 2026-11-05. Put any of them next to GMED in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Globus Medical trade when bond yields rise?

Over the past year Globus Medical had a beta of 0.86 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 74% of US names. On the 10 sessions in which long bonds fell most it moved −0.94% on average, against −0.74% for the S&P 500. As of 2026-11-06; The "How it trades on rate days" block on this page carries the lines.

What does Globus Medical do?

Globus Medical makes implants and instruments for spine, orthopaedic trauma and hip-and-knee surgery, treating musculoskeletal disorders. It also builds the ExcelsiusGPS robotic guidance platform and related navigation and neuromonitoring tools used during procedures. The company is based in Audubon, United States, and sells through direct and distributor channels in the US and abroad. Closelooknet's peer group places it with regulated medical-device and animal-health names — IDEXX Laboratories, Intuitive Surgical, Sonova, Stryker, Sartorius, DexCom and Insulet — grouped for their multi-decade regulatory moats; the market also compares it with Medtronic. (Company snapshot of 2026-09-17.)

Where does Globus Medical sit in the AI build-out?

Globus Medical carries no seat in Rubin or Halo, our AI-stack indices; it sits instead in the HALO Growth 100, our growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve, a group of regulated device and diagnostics compounders. Globus Medical is a HALO Growth 100 constituent and carries a Closelooknet score across seven modules, where valuation reads strongest and momentum weakest; the diary has not yet quoted it directly. (Company snapshot of 2026-09-17.)

Does Globus Medical pay a dividend?

No cash distribution shows in Globus Medical’s price series over the last three years. In fiscal 2025 the company bought back 300 m USD of its own shares, 51% of that year’s free cash flow. The share count fell 0.5% over the fiscal year. As of 2026-11-06; the "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Globus Medical recently?

The most recent analyst action on Globus Medical on the Closelooknet wire is a downgrade by BMO Capital on 2026-11-06 (Outperform → Market Perform). 2 actions on the analyst wire since 2026-08-13: 1 downgrade, 1 target change. Its latest earnings print on the wire, 2026-11-05: EPS 1.23 against 1.20 expected — a +2.5% beat. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for GMED, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

How to use this chart

Toolbar

  • Range — 1M to MAX on daily closes. 1D/5D switch a US stock cell to 5-minute intraday bars; index and foreign cells fall back to 1M daily with a note.
  • Grid — 1×1 up to 2×2. Cells are synchronized: pan or zoom one and the others follow the same dates; the crosshair tracks across all of them. 4 INDICES loads Rubin · HALO · AEI · AW40 side by side.
  • Type / Scale — OHLC, line or area; linear or log price axis.

Picking a series

  • Tap the box in a cell's header to browse every Closelooknet series — headline indices, sub-indices, sectors, layers of all six families — plus the constituents.
  • Or type any ticker (NVDA, 7203.T, ASML.AS …) and press Enter — it charts in the cell straight from our data lake.

Studies

  • Overlays / Oscillators rows toggle the standard set (SMA, Bollinger, RSI, MACD …) per cell.
  • Levels (stock cells) draws the structure engine's support lines — regression bands, pivot cluster, SMA-200, the active fib zone.

Drawing

  • Tap a tool (Trend, Ray, H-Line, Fib, Channel, Rect, Note), then tap the chart once per point — the shape follows your finger or cursor between taps. The chart stops panning while a tool is armed; tap the tool again to release.
  • Drawings save per symbol in this browser and travel between the terminal and the asset page.
  • Delete key removes the selected drawing · Escape cancels a half-placed one · Clear wipes the symbol.

Wave counts

  • Wave places an Elliott count: tap the origin, then each wave end. Press Enter to stop early (inside wave 3 is fine) — dotted ghost targets sketch the remaining waves at guideline ratios.
  • On stocks the scanner's machine count appears automatically in grey — it is fully editable: drag any point, double-tap a label to remove it, Delete to dismiss it for good, Adopt to bring the machine's proposal back.
  • The sequence picker switches 1-5 / A-B-C / A-E / W-X-Y-Z; 1 2 3 cycles the degree; Subdiv starts a one-degree-smaller child count inside a wave.

Sharing

  • Card exports the cell as a branded PNG — chart, drawings and levels exactly as shown.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.